These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15670697)
1. Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach. Meyer PT; Elmenhorst D; Bier D; Holschbach MH; Matusch A; Coenen HH; Zilles K; Bauer A Neuroimage; 2005 Feb; 24(4):1192-204. PubMed ID: 15670697 [TBL] [Abstract][Full Text] [Related]
2. Simplified quantification of cerebral A1 adenosine receptors using [18F]CPFPX and PET: analyses based on venous blood sampling. Meyer PT; Elmenhorst D; Zilles K; Bauer A Synapse; 2005 Mar; 55(4):212-23. PubMed ID: 15668990 [TBL] [Abstract][Full Text] [Related]
3. Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET. Meyer PT; Bier D; Holschbach MH; Boy C; Olsson RA; Coenen HH; Zilles K; Bauer A J Cereb Blood Flow Metab; 2004 Mar; 24(3):323-33. PubMed ID: 15091113 [TBL] [Abstract][Full Text] [Related]
4. In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments. Elmenhorst D; Kroll T; Wedekind F; Weisshaupt A; Beer S; Bauer A J Nucl Med; 2013 Aug; 54(8):1411-9. PubMed ID: 23740103 [TBL] [Abstract][Full Text] [Related]
5. A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans. Meyer PT; Elmenhorst D; Matusch A; Winz O; Zilles K; Bauer A Neuroimage; 2006 Sep; 32(3):1100-5. PubMed ID: 16806981 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of the A1 adenosine receptor PET ligand [18F]CPFPX by CYP1A2: implications for bolus/infusion PET studies. Matusch A; Meyer PT; Bier D; Holschbach MH; Woitalla D; Elmenhorst D; Winz OH; Zilles K; Bauer A Nucl Med Biol; 2006 Oct; 33(7):891-8. PubMed ID: 17045169 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET. Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487 [TBL] [Abstract][Full Text] [Related]
8. 18F-CPFPX PET: on the generation of parametric images and the effect of scan duration. Meyer PT; Elmenhorst D; Matusch A; Winz O; Zilles K; Bauer A J Nucl Med; 2006 Feb; 47(2):200-7. PubMed ID: 16455624 [TBL] [Abstract][Full Text] [Related]
9. Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET. Elmenhorst D; Meyer PT; Matusch A; Winz OH; Zilles K; Bauer A Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1061-70. PubMed ID: 17242921 [TBL] [Abstract][Full Text] [Related]
10. Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET. Elmenhorst D; Meyer PT; Matusch A; Winz OH; Bauer A J Nucl Med; 2012 Nov; 53(11):1723-9. PubMed ID: 22966134 [TBL] [Abstract][Full Text] [Related]
11. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans. Meyer PT; Elmenhorst D; Boy C; Winz O; Matusch A; Zilles K; Bauer A Neurobiol Aging; 2007 Dec; 28(12):1914-24. PubMed ID: 16996650 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans. Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116 [TBL] [Abstract][Full Text] [Related]
13. Adenosine A(1) receptors in human brain and transfected CHO cells: Inhibition of [(3)H]CPFPX binding by adenosine and caffeine. Elmenhorst D; Garibotto V; Prescher A; Bauer A Neurosci Lett; 2011 Jan; 487(3):415-20. PubMed ID: 21056087 [TBL] [Abstract][Full Text] [Related]
14. Optimal duration of PET studies with 18F-fluoroethyl-diprenorphine. Boecker H; Sprenger T; Henriksen G; Toelle TR; Spilker ME J Nucl Med; 2005 Dec; 46(12):2092-6. PubMed ID: 16330575 [TBL] [Abstract][Full Text] [Related]
15. 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion. Bauer A; Langen KJ; Bidmon H; Holschbach MH; Weber S; Olsson RA; Coenen HH; Zilles K J Nucl Med; 2005 Mar; 46(3):450-4. PubMed ID: 15750158 [TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine. Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K J Nucl Med; 2005 Jan; 46(1):32-7. PubMed ID: 15632030 [TBL] [Abstract][Full Text] [Related]
17. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Boy C; Meyer PT; Kircheis G; Holschbach MH; Herzog H; Elmenhorst D; Kaiser HJ; Coenen HH; Haussinger D; Zilles K; Bauer A Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):589-97. PubMed ID: 18000666 [TBL] [Abstract][Full Text] [Related]
18. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843 [TBL] [Abstract][Full Text] [Related]
19. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705 [TBL] [Abstract][Full Text] [Related]
20. Simplifications in analyzing positron emission tomography data: effects on outcome measures. Logan J; Alexoff D; Kriplani A Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]